Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients

by J. M. Ruiz-Moreno, F. de Andrés-Nogales, I. Oyagüez
Published 2020-09-01

Cost analysis of the use of botulinum toxin type A in Spain

by F. de Andrés-Nogales, A. Morell, J. Aracil, C. Torres, I. Oyagüez, M. A. Casado
Published 2014-05-01

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain

by R. Ariza, A. van Walsem, C. Canal, C. Roldán, L. Betegón, I. Oyagüez, K. Janssen
Published 2014-07-01

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain

by R. Ibáñez, M. Mareque, R. Granados, D. Andía, M. García-Rojo, J. C. Quílez, I. Oyagüez
Published 2021-04-01

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain

by M. Sanchez-Luna, R. Burgos-Pol, I. Oyagüez, J. Figueras-Aloy, M. Sánchez-Solís, F. Martinón-Torres, X. Carbonell-Estrany
Published 2017-10-01

Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer

by M.ª Echave, C. Pericay, C. Frías, A. Abad, M.ª J. Lamas, I. Oyagüez, M. Rubio, M. Rubio, E. Giménez, S. Naoshy, F. Joulain
Published 2014-07-01